This site is intended for healthcare professionals only
LoginRegister
NPPA Orders Strict Monitoring of 30% Trade Margin Cap on 137 Cancer Drugs, Warns of Penal ActionNPPA Orders Strict Monitoring of 30% Trade Margin Cap on 137 Cancer Drugs, Warns of Penal Action
Zydus Lifesciences UK LiqMeds Facility Gets 4 USFDA Inspection ObservationsZydus Lifesciences' UK LiqMeds Facility Gets 4 USFDA Inspection Observations
Orchid Pharma Signs USD 178 Million Russia Licensing Deal for Antibiotic ExblifepPharma Firm Founder, Wife Face Insolvency Proceedings Over Rs 256.29 Crore Dues
Natco Pharma Q2 Net Profit Plunges 61% to Rs 203 Crore as Revenue Falls 29%Natco Pharma Q2 Net Profit Plunges 61% to Rs 203 Crore as Revenue Falls 29%
Takedas Narcolepsy Drug Orzeyful Hits US MarketTakeda's Narcolepsy Drug Orzeyful Hits US Market
Eli Lillys Oral Obesity Drug Orforglipron Gets China Approval, Challenging Novos WegovyEli Lilly's Oral Obesity Drug Orforglipron Gets China Approval, Challenging Novo's Wegovy
Delhi HC Grants Finecure Interim Relief Over Alleged Copying of Website, Business CredentialsDelhi HC Grants Finecure Interim Relief Over Alleged Copying of Website, Business Credentials
India Mulls Allowing MNCs to Conduct First-in-Human Phase I Clinical TrialsIndia Mulls Allowing MNCs to Conduct First-in-Human Phase I Clinical Trials
Cohance Lifesciences Pashamylaram Facility Gets USFDA EIR With VAI StatusCohance Lifesciences' Pashamylaram Facility Gets USFDA EIR With VAI Status
Alkem Laboratories Appoints Gopal Kothari as Chief Financial OfficerAlkem Laboratories Appoints Gopal Kothari as Chief Financial Officer
Zydus Lifesciences Acquires 50% Stake in Joint Venture With Sunshine Healthcare LankaZydus Lifesciences Acquires 50% Stake in Joint Venture With Sunshine Healthcare Lanka
USFDAs Fast-Track Drug Review Programme Under Trump Administration Falls Into LimboUSFDA's Fast-Track Drug Review Programme Under Trump Administration Falls Into Limbo
X